SYK — STRYKER CORPORATION
Health Care · Medical Devices
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying SYK?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their SYK position last quarter, 0 bought and 1 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime). 0 congressional purchases, 2 sales disclosed in the last 6 months.
- +5 tracked investors reported holding SYK at their latest filing
- −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
- −Congressional disclosures lean toward selling (2 sales vs 0 purchases, 6 months)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.
About STRYKER CORPORATION (SYK)
STRYKER CORPORATION (SYK) appears in the most recent 13F filings of 5 tracked institutional investors. STRYKER CORPORATION is classified in the Health Care sector (Medical Devices industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $191M. Across recent filings, tracked investors recorded 2 new positions, 2 increased, 10 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in SYK
How many top investors track SYK
A small number of top investors own this.
SYK Ownership Composition
How STRYKER CORPORATION is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant96.3%
- Macro3.7%
Tracked investors currently reporting SYK
- Ken GriffinJun 30, 2026Citadel AdvisorsShares555.1KValue$174.8M% Portfolio0.02%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares144.9KValue$45.6M% Portfolio0.02%
- Steve CohenJun 30, 2026Point72 Asset ManagementShares446.4KValue$140.5M% Portfolio0.15%
- Ray DalioJun 30, 2026Bridgewater AssociatesShares12.2KValue$3.8M% Portfolio0.02%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares32.3KValue$10.2M% Portfolio0.01%
Recent activity
- Reduced$121.3M(-2.05%)Feb 14, 2024
- Reduced$118.1M(-18.56%)May 14, 2024
- Reduced$104.4M(-7.00%)Aug 14, 2024
- Reduced$21.4M(-80.69%)Nov 13, 2024
- Reduced$14.4M(-32.70%)Feb 13, 2025
- Reduced$5.8M(-61.16%)May 14, 2025
- Reduced$4.7M(-23.36%)Aug 13, 2025
- Increased$4.5K(1.98%)Nov 13, 2025
- Increased$11.6K(172.67%)Feb 13, 2026
- Reduced$8.7M(-19.97%)May 15, 2026
- Reduced$3.8M(-53.98%)Aug 14, 2026
- Reduced$1.3M(-66.82%)Aug 14, 2024
- Sold$0(-100.00%)Nov 14, 2024
- New$113MNov 13, 2023
- $4.1MMay 15, 2024
Frequently asked questions
- How many institutional investors hold SYK?
- 5 tracked institutional investors disclosed a position in SYK (STRYKER CORPORATION) in their most recent 13F filing.
- Who is the largest institutional holder of SYK?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in SYK, valued at $191M.
- Did institutional ownership of SYK increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 2 increased, 10 reduced, and 1 fully exited SYK.
- What sector is SYK in?
- STRYKER CORPORATION is classified in the Health Care GICS sector, Medical Devices industry.
- Where does this SYK ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.